25mg mono therapy has 40% patient successes i.e HBSAG dicrease in 40% patients. 2nd chohurt 50 mg results due for next moth.I think 50mg also succeeded because they started 100mg chohurt recently.I think springbankpharm is going good. in 1H2018 they are starting combo with Gilead.
What do you guys think about NASVAC?, I am hearing its news regularly in BANLGLADESH. Its going to be approved in banladesh very soon with 50% success rate as per news.
This med came all of a sudden. Hope it's further trials go successful